DalsnaFinance › IPOs › Inhibikase Therapeutics Inc › IPO
Inhibikase Therapeutics, Inc. completed its initial public offering on NASDAQ on December 23, 2020, pricing at $10.00 a share.
| Ticker | IKT |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | December 23, 2020 |
| Offering price | $10.00 |
| Shares offered | 1,800,000 |
| Total raised | $18M |
Inhibikase Therapeutics, Inc. sold 1,800,000 shares at $10.00 each on NASDAQ. Multiplied out, that is $18 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $18 million total recorded for the deal.
Inhibikase Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Inhibikase Therapeutics, Inc.. This page is general information, not investment advice.